Evidence map›Paper›PMID 28167547›Full record

ArticleAntimicrobial agents and chemotherapy2017

Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.

Michael J Satlin, Liang Chen, Gopi Patel, Angela Gomez-Simmonds, Gregory Weston, Angela C Kim, Susan K Seo, Marnie E Rosenthal, Steven J Sperber, Stephen G Jenkins and 13 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed, 6 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 6 syntheses or guidelines pooled it, 244 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Differential virulence potential of different clades of multidrug-resistantmedRxiv : the preprint server for health sciences · 2026
    Article
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Article

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 1 country.

Michael J SatlinDivision of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA mjs9012@med.cornell.edu.
Liang ChenPublic Health Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Gopi PatelDivision of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Angela Gomez-SimmondsDivision of Infectious Diseases, Columbia University Medical Center, New York, New York, USA.
Gregory WestonDivision of Infectious Diseases, Albert Einstein College of Medicine, Bronx, New York, USA.
Angela C KimDivision of Infectious Diseases, Northwell Health, Manhasset, New York, USA.
Susan K SeoInfectious Diseases Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Marnie E RosenthalDepartment of Medicine, Jersey Shore University Medical Center, Neptune City, New Jersey, USA.
Steven J SperberDivision of Infectious Diseases, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Stephen G JenkinsDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Camille L HamulaDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Anne-Catrin UhlemannDivision of Infectious Diseases, Columbia University Medical Center, New York, New York, USA.
Michael H LeviDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York, USA.
Bettina C FriesDivision of Infectious Diseases, Albert Einstein College of Medicine, Bronx, New York, USA.
Yi-Wei TangDepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0003-4888-6771
Stefan JuretschkoDepartment of Pathology, Northwell Health, Manhasset, New York, USA.
Albert D RojtmanDepartment of Pathology, Jersey Shore University Medical Center, Neptune City, New Jersey, USA.
Tao HongDepartment of Pathology, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Barun MathemaDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
Michael R JacobsDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Thomas J WalshDivision of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.
Robert A BonomoMedical Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.
Barry N KreiswirthPublic Health Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Albert Einstein College of Medicine · USCornell University · USColumbia University Irving Medical Center · USHackensack University Medical Center · USIcahn School of Medicine at Mount Sinai · USMemorial Sloan Kettering Cancer Center · USNorthwell Health · USRutgers, The State University of New Jersey · USColumbia University · USJersey Shore University Medical Center · USLouis Stokes Cleveland VA Medical Center · USSaint Peter's University Hospital · USUniversity School · US

Funding

The molecular basis of the epidemic blaKPC gene KlebsiellaR01AI090155 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KREISWIRTH, BARRY NEAL · 2011 to 2021
$7.2M
Carbapenem-resistant bacterial colonization and infection after liver transplantR01AI116939 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI UHLEMANN, ANNE-CATRIN · 2015 to 2019
$2.4M
Rapid Identification of Neutropenic Patients at High Risk of CRE BacteremiaK23AI114994 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SATLIN, MICHAEL JOSEPH · 2015 to 2019
$925k
Genomic variation in epidemic carbapenem-resistant K.pneumoniaeR21AI117338 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI CHEN, LIANG · 2016 to 2017
$437k
Development of antibodies to capsule of carbapenem resistant Klebsiella pneumoniaR21AI114259 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI FRIES, BETTINA · 2015 to 2016
$435k
NIAID NIH HHS K23 AI114994NIAID NIH HHS R01 AI090155NIAID NIH HHS R01 AI116939NIAID NIH HHS R21 AI117338
6 · The paper itself

Abstract

Although the New York/New Jersey (NY/NJ) area is an epicenter for carbapenem-resistant

Indexed as

Anti-Bacterial AgentsBacteremiaCarbapenemsEnterobacterEnterobacteriaceaeEscherichia coliHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsMolecular EpidemiologyAnti-Bacterial AgentsCarbapenemscarbapenem-resistant Enterobacteriaceaeclinical outcomesmolecular epidemiologyresistance mechanisms

Identifiers

PMID28167547
PMCPMC5365653
OpenAlexW2587715799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.